HL Variable Terminology

Preferred Label : HL Variable Terminology;

NCIt synonyms : Hodgkin Lymphoma Variable Terminology;

NCIt definition : Terms that have been designated as being a variable within the PCDC Terminology and HL project.;

NCI Metathesaurus CUI : CL1778562;

Détails

Origin ID

C186342;

UMLS CUI

C5670469;

Semantic type(s)
- Intellectual Product [UMLS semantic type]
concept_is_in_subset
- PCDC Terminology [NCIt concept]
subset_includes_concept
- Adverse Event [NCIt concept]
- Adverse Event Attribution to Product or Procedure [NCIt concept]
- Adverse Event Code [NCIt concept]
- Adverse Event Expected Indicator [NCIt concept]
- Adverse Event Grading System [NCIt concept]
- Adverse Event Intervention [NCIt concept]
- Adverse Event Medication [NCIt concept]
- Adverse Event Modification or Adjustment [NCIt concept]
- Adverse Event Outcome [NCIt concept]
- Adverse Event Pathogen [NCIt concept]
- Adverse Event Reported [NCIt concept]
- Adverse Event Severity Grade [NCIt concept]
- Adverse Event System Grading Version [NCIt concept]
- Adverse Event associated with Hospitalization [NCIt concept]
- Age In Days at Histology Assessment [NCIt concept]
- Age in Days When Lost to Follow-up [NCIt concept]
- Age in Days When Off Protocol Therapy or Study [NCIt concept]
- Age in Days at Adverse Event Resolution [NCIt concept]
- Age in Days at Cycle End [NCIt concept]
- Age in Days at Cycle Start [NCIt concept]
- Age in Days at Disease Phase [NCIt concept]
- Age in Days at End of Concomitant Medication Administration [NCIt concept]
- Age in Days at End of Radiation Therapy [NCIt concept]
- Age in Days at End of Total Dose Calculation [NCIt concept]
- Age in Days at End of Treatment Course [NCIt concept]
- Age in Days at Enrollment [NCIt concept]
- Age in Days at Function Test [NCIt concept]
- Age in Days at Imaging [NCIt concept]
- Age in Days at Immunohistochemistry [NCIt concept]
- Age in Days at Last Known Survival Status [NCIt concept]
- Age in Days at Late Effect Evaluation [NCIt concept]
- Age in Days at Lesion Assessment [NCIt concept]
- Age in Days at Onset Adverse Event [NCIt concept]
- Age in Days at Procedure [NCIt concept]
- Age in Days at Radiation Therapy Course Start [NCIt concept]
- Age in Days at Response Assessment [NCIt concept]
- Age in Days at Secondary Malignancy Neoplasm [NCIt concept]
- Age in Days at Start of Concomitant Medication Administration [NCIt concept]
- Age in Days at Start of Total Dose Calculation [NCIt concept]
- Age in Days at Start of Transfusion Procedure [NCIt concept]
- Age in Days at Start of Treatment Course [NCIt concept]
- Age in Days at Stem Cell Transplant [NCIt concept]
- Age in Days at Time of Laboratory Test [NCIt concept]
- Age in Days at Vitals [NCIt concept]
- Age in Days of Protocol Treatment Modification [NCIt concept]
- Age in Days of Staging Assessment [NCIt concept]
- Agent Substitution [NCIt concept]
- Ann Arbor A vs B Staging Designation [NCIt concept]
- Ann Arbor Extranodal Involvement Indicator [NCIt concept]
- Ann Arbor Splenic Involvement Modifier [NCIt concept]
- Antineoplastic Agent [NCIt concept]
- Biopsy Procedure [NCIt concept]
- Bulky Disease [NCIt concept]
- Bulky Lesion [NCIt concept]
- Bulky Mediastinal Mass [NCIt concept]
- Bulky Nodal Disease [NCIt concept]
- CTCAE Version [NCIt concept]
- Cause of Death [NCIt concept]
- Cause of Death Detail [NCIt concept]
- Cause of Death Ranking [NCIt concept]
- Change Reason [NCIt concept]
- Chemotherapeutic Cycle Number [NCIt concept]
- Conceived Through Assisted Conception [NCIt concept]
- Concomitant Agent [NCIt concept]
- Cumulative Dose [NCIt concept]
- Data Contributor ID [NCIt concept]
- Diameter Dimension 1 Orientation [NCIt concept]
- Diameter Dimension 2 Orientation [NCIt concept]
- Diameter Dimension 3 Orientation [NCIt concept]
- Disease Involvement Detection Method [NCIt concept]
- Disease Phase [NCIt concept]
- Disease Phase Number [NCIt concept]
- Disease Response [NCIt concept]
- Enrolled in Another Therapeutic Study After Off Study [NCIt concept]
- Ethnic Group [NCIt concept]
- Extent of Resection [NCIt concept]
- Extranodal Site of the Extended Lesion [NCIt concept]
- Family Medical History [NCIt concept]
- Fever [NCIt concept]
- Focal Splenic Involvement by Hodgkin Lymphoma with Hilar Lymphadenopathy [NCIt concept]
- Function Category [NCIt concept]
- Function Result [NCIt concept]
- Function Result Measurement [NCIt concept]
- Function Result Numeric [NCIt concept]
- Function Result Unit [NCIt concept]
- High Threshold [NCIt concept]
- Histology [NCIt concept]
- Honest Broker Subject ID [NCIt concept]
- Imaging Finding [NCIt concept]
- Imaging Procedure [NCIt concept]
- Immune Related Adverse Event [NCIt concept]
- Immunohistochemical Test [NCIt concept]
- Immunohistochemical Test Result [NCIt concept]
- Immunohistochemistry Specimen Type [NCIt concept]
- Immunohistochemistry Test Numeric Result [NCIt concept]
- Immunohistochemistry Test Result Unit [NCIt concept]
- Immunotoxicity [NCIt concept]
- Infusion Related Adverse Event [NCIt concept]
- Infusion Related Toxicity [NCIt concept]
- Interim Response [NCIt concept]
- Karnofsky Performance Status [NCIt concept]
- Laboratory Specimen Type [NCIt concept]
- Laboratory Test Category [NCIt concept]
- Laboratory Test Method [NCIt concept]
- Laboratory Test Name [NCIt concept]
- Laboratory Test Numeric Result in Standard Unit [NCIt concept]
- Laboratory Test Original Result Unit [NCIt concept]
- Laboratory Test Result [NCIt concept]
- Lansky Play-Performance Status [NCIt concept]
- Last Known Survival Status [NCIt concept]
- Last Known Survival Status with Disease [NCIt concept]
- Late Adverse Effect [NCIt concept]
- Late Effect Sub Details [NCIt concept]
- Late Effects Details [NCIt concept]
- Late Effects Severity Grade [NCIt concept]
- Lesion Assessment Review Institution [NCIt concept]
- Lesion Characteristics Detection Method [NCIt concept]
- Lesion Classification [NCIt concept]
- Lesion Laterality [NCIt concept]
- Lesion Percentage of Change [NCIt concept]
- Lesion Site [NCIt concept]
- London Deauville Criteria Point Scale [NCIt concept]
- Longest Diameter Dimension 1 [NCIt concept]
- Longest Diameter Dimension 2 [NCIt concept]
- Longest Diameter Dimension 3 [NCIt concept]
- Low Threshold [NCIt concept]
- Lower Age Range of Child Rater [NCIt concept]
- Measurement of CD34 Stem Cells Collected [NCIt concept]
- Mediastinal Width Ratio [NCIt concept]
- Medical History Category [NCIt concept]
- Medication Course Number [NCIt concept]
- Medication Intended Route Effect [NCIt concept]
- Modification Type [NCIt concept]
- Neoplasm Stage [NCIt concept]
- Night Sweats [NCIt concept]
- Non-Protocol Stem Cell Type Transplant Type [NCIt concept]
- Non-Protocol Therapy Timing [NCIt concept]
- Non-Protocol Therapy Type [NCIt concept]
- Number of Doses [NCIt concept]
- Number of Lymph Nodes Examined [NCIt concept]
- Number of Units of Product Transfused [NCIt concept]
- Numeric Vitals Signs Result [NCIt concept]
- Off Protocol Therapy or Study Code [NCIt concept]
- Original Agent [NCIt concept]
- Outcomes Study Identifier [NCIt concept]
- PCDC Subject Identifier [NCIt concept]
- Palpable Lymph Node [NCIt concept]
- Pathogen Confirmation Indicator [NCIt concept]
- Patient-Reported Outcomes Measurement Information System Measures [NCIt concept]
- Patient-Reported Outcomes Measurement Type [NCIt concept]
- Pericardial Effusion [NCIt concept]
- Personal Medical History [NCIt concept]
- Pleural Effusion [NCIt concept]
- Prior Cancer Type [NCIt concept]
- Procedure Purpose [NCIt concept]
- Protocol Treatment Arm [NCIt concept]
- Protocol Treatment Course [NCIt concept]
- Race [NCIt concept]
- Radiation Boost Dose [NCIt concept]
- Radiation Dose Unit [NCIt concept]
- Radiation Therapy [NCIt concept]
- Radiation Therapy Laterality [NCIt concept]
- Raters Allowed to Report PRO [NCIt concept]
- Reason Off Protocol [NCIt concept]
- Reason for Medication Administration [NCIt concept]
- Red Blood Cells Product [NCIt concept]
- Reference Time Point [NCIt concept]
- Relative [NCIt concept]
- Response Assessment Category [NCIt concept]
- Response Assessment Method [NCIt concept]
- Response in Target Lesion [NCIt concept]
- Route of Administration [NCIt concept]
- SMN ICD-O Morphology Code [NCIt concept]
- SMN ICD-O Topography Code [NCIt concept]
- SMN Relationship to Radiation Field [NCIt concept]
- Sex [NCIt concept]
- Single or Multiple Lymph Node Involvement Question [NCIt concept]
- Site of Radiation Therapy [NCIt concept]
- Staging System [NCIt concept]
- Stem Cell Transplant Donor Relationship [NCIt concept]
- Stem Cell Transplant Source [NCIt concept]
- Study Identifier [NCIt concept]
- Study Type [NCIt concept]
- Surgical Procedure by Type [NCIt concept]
- Surgical Site [NCIt concept]
- Symptomatic [NCIt concept]
- Total Dose Intended [NCIt concept]
- Total Dose Units [NCIt concept]
- Total Radiation Dose [NCIt concept]
- Toxicity Details [NCIt concept]
- Transfusion Product [NCIt concept]
- Transfusion Product Processing [NCIt concept]
- Transfusion Type [NCIt concept]
- Treatment Modification Rationale [NCIt concept]
- Treatment-related Mortality Type [NCIt concept]
- Trial Phase [NCIt concept]
- Type of Stem Cell Transplant [NCIt concept]
- Type of Stem Cell Transplant Conditioning Prior to Transplant Question [NCIt concept]
- Upper Age Range of Child Rater [NCIt concept]
- Vital Signs Measurement [NCIt concept]
- Vital Signs Original Result Unit [NCIt concept]
- Vital Signs Result [NCIt concept]
- Weight Loss [NCIt concept]
- Year at Disease Phase [NCIt concept]
- qPET Score [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients